table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 hospitalized
COVID-19 severe or critically
anticoagulant
anticoagulant, curative dose REMAP-CAP, ACTIV-4a, ATTACC ... COVID-PACT
anticoagulant, prophylactic dose Tang
anticoagulation, intermediate prophylactic dose INSPIRATION
heparin at therapeutic dose ACTIV-4a ... REMAP-CAP Anticoagulation ATTACC ...

1 studies excluded by filtering options 2

6405 Li [retracted], 2020 200excludedrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons